Clinical Trial Update: Vemurafenib and Panitumumab Combination Therapy in Patients With BRAF V600E Mutated Metastatic Colorectal Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the safety and preliminary efficacy of combining vemurafenib with panitumumab in patients with BRAF V600E-mutated metastatic colorectal…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Panitumumab (panitumumab)
• Vemurafenib (vemurafenib)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Metastatic Colorectal Cancer | Phase 1 | Status: COMPLETED